Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
8.70
+0.02 (0.23%)
At close: Dec 20, 2024, 4:00 PM
8.74
+0.04 (0.46%)
After-hours: Dec 20, 2024, 7:32 PM EST
Novavax Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Novavax stock have an average target of 17.83, with a low estimate of 9.00 and a high estimate of 26. The average target predicts an increase of 104.94% from the current stock price of 8.70.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Novavax stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +118.39% | Dec 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +118.39% | Nov 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +118.39% | Nov 12, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $31 → $25 | Strong Buy | Maintains | $31 → $25 | +187.36% | Oct 16, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $23 → $26 | Strong Buy | Reiterates | $23 → $26 | +198.85% | Oct 10, 2024 |
Financial Forecast
Revenue This Year
697.76M
from 983.71M
Decreased by -29.07%
Revenue Next Year
568.30M
from 697.76M
Decreased by -18.55%
EPS This Year
-1.46
from -5.41
EPS Next Year
0.08
from -1.46
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 732.3M | 1.1B | 943.3M | |||
| Avg | 697.8M | 568.3M | 665.1M | |||
| Low | 660.4M | 223.4M | 348.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -25.6% | 55.1% | 66.0% | |||
| Avg | -29.1% | -18.6% | 17.0% | |||
| Low | -32.9% | -68.0% | -38.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -1.20 | 2.47 | 2.28 | |||
| Avg | -1.46 | 0.08 | 0.95 | |||
| Low | -1.67 | -1.62 | -0.47 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | 2,580.7% | |||
| Avg | - | - | 1,022.0% | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.